1. Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Issue 8 (3rd July 2022) Authors: Freyer, Craig W.; Carulli, Alison; Gier, Shannon; Ganetsky, Alex; Timlin, Colleen; Schuster, Mindy; Babushok, Daria; Frey, Noelle V.; Gill, Saar I.; Hexner, Elizabeth O.; Luger, Selina M.; Mangan, James K.; Martin, Mary Ellen; McCurdy, Shannon R.; Perl, Alexander E.; Porter, David L.; Pratz, Keit... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 1925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Salvage therapy with basiliximab and etanercept for severe steroid‐refractory acute graft‐versus‐host disease. Issue 7 (22nd April 2022) Authors: Freyer, Craig W.; Gier, Shannon; Carulli, Alison; Gill, Saar I.; Hexner, Elizabeth O.; Loren, Alison W.; Martin, Mary Ellen; Porter, David L. Journal: American journal of hematology Issue: Volume 97:Issue 7(2022) Page Start: E273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗